Pages that link to "Q40955120"

The following pages link to Highly Selective Dopamine D3 Receptor (D3R) Antagonists and Partial Agonists Based on Eticlopride and the D3R Crystal Structure: New Leads for Opioid Dependence Treatment. (Q40955120):

Displaying 17 items.

• Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds (Q38656262) (← links)
• Current and Future Challenges in GPCR Drug Discovery (Q47348761) (← links)
• Targeting hypersensitive corticostriatal terminals in restless legs syndrome (Q47952336) (← links)
• Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism (Q48116846) (← links)
• Atypical dopamine transporter inhibitors attenuate compulsive-like methamphetamine self-administration in rats. (Q50023810) (← links)
• Regional Heterogeneity of D2-Receptor Signaling in the Dorsal Striatum and Nucleus Accumbens. (Q52317816) (← links)
• [--C]-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1-indole-2-carboxamide ([C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D₃ Receptors in Rodents and Monkey (Q58576516) (← links)
• Novel and Potent Dopamine D Receptor Go-Protein Biased Agonists (Q61817695) (← links)
• Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats (Q89957847) (← links)
• Insights From Molecular Dynamics Simulations of a Number of G-Protein Coupled Receptor Targets for the Treatment of Pain and Opioid Use Disorders (Q90049722) (← links)
• Newly Developed Dopamine D3 Receptor Antagonists, R-VK4-40 and R-VK4-116, Do Not Potentiate Cardiovascular Effects of Cocaine or Oxycodone in Rats (Q90339007) (← links)
• A Medicinal Chemist's Journey at the National Institutes of Health One Molecule at a Time (Q90412585) (← links)
• Dopamine D3R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement without compromising its antinociceptive effects (Q90568986) (← links)
• Molecular pharmacology of metabotropic receptors targeted by neuropsychiatric drugs (Q91595350) (← links)
• Multitarget compounds for bipolar disorder: from rational design to preliminary pharmacokinetic evaluation (Q91729364) (← links)
• Dopamine D3 Receptor Antagonism Reverses the Escalation of Oxycodone Self-administration and Decreases Withdrawal-Induced Hyperalgesia and Irritability-Like Behavior in Oxycodone-Dependent Heterogeneous Stock Rats (Q93013726) (← links)
• Structure-activity relationships for a series of (Bis(4-fluorophenyl)methyl)sulfinylethyl-aminopiperidines and -piperidine amines at the dopamine transporter: Bioisosteric replacement of the piperazine improves metabolic stability (Q99569686) (← links)